Trials / Completed
CompletedNCT04448275
Effect of Neurodynamics Nerve Flossing on Femoral Neuropathy in Haemophilic Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Lama Saad El-Din Mahmoud · Academic / Other
- Sex
- Male
- Age
- 12 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of Neurodynamics Nerve flossing on femoral neuropathy in patients with haemophilia Background: heamophilia is one of the serious chronic disorders in children and adolescents which results in less physical activities and restlessness hours than their peer. HYPOTHESES: This study will hypnotize that: Neurodynamics Nerve flossing will have a significant effect on femoral neuropathy in patients with haemophilia RESEARCH QUESTION: will the Neurodynamics Nerve flossing has an effect on femoral neuropathy in patients with haemophilia?
Detailed description
Haemophilic patients with Femoral Neuropathy will be randomly divided in two equal groups control group which will receive conventional selected exercise program and study group will receive the same exercise training program in addition to Neurodynamics Nerve flossing three times per week for three successive months. The Evaluation will done pre and post interventions included: femoral nerve motor conduction velocity, muscle test For Iliopsoas and Quadriceps muscles and Pain visual analogue scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neurodynamics Nerve flossing | Neurodynamics Nerve flossing for femoral nerve that includes two techniques inform of: "slider technique" and the second is the "tensioner technique |
| OTHER | conventional selected exercise program | Ultrasound therapy The flexibility exercises for iliopsoas \& quadriceps The iliopsoas \& quadriceps muscles strength exercise |
Timeline
- Start date
- 2020-06-30
- Primary completion
- 2020-09-30
- Completion
- 2020-10-30
- First posted
- 2020-06-25
- Last updated
- 2021-01-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04448275. Inclusion in this directory is not an endorsement.